25 related articles for article (PubMed ID: 28427866)
1. Melatonin receptor stimulation by agomelatine prevents Aβ-induced tau phosphorylation and oxidative damage in PC12 cells.
Yao K; Zhao YF; Zu HB
Drug Des Devel Ther; 2019; 13():387-396. PubMed ID: 30718944
[TBL] [Abstract][Full Text] [Related]
2. Amyloid-beta induced CA1 pyramidal cell loss in young adult rats is alleviated by systemic treatment with FGL, a neural cell adhesion molecule-derived mimetic peptide.
Corbett NJ; Gabbott PL; Klementiev B; Davies HA; Colyer FM; Novikova T; Stewart MG
PLoS One; 2013; 8(8):e71479. PubMed ID: 23951173
[TBL] [Abstract][Full Text] [Related]
3. A Brain Ischemia-Reperfusion Model for the Study of Tau Phosphorylation and O-GlcNAcylation.
Vera-González A; Cardozo CF; Araque EV; Cruz MJ; Arango-Davila CA; Rengifo-Gómez J
Methods Mol Biol; 2024; 2754():581-600. PubMed ID: 38512691
[TBL] [Abstract][Full Text] [Related]
4. Effects of phenothiazine-structured compounds on APP processing in Alzheimer's disease cellular model.
Yuksel M; Biberoglu K; Onder S; Akbulut KG; Tacal O
Biochimie; 2017 Jul; 138():82-89. PubMed ID: 28457944
[TBL] [Abstract][Full Text] [Related]
5. Implications of Glycosylation in Alzheimer's Disease.
Haukedal H; Freude KK
Front Neurosci; 2020; 14():625348. PubMed ID: 33519371
[TBL] [Abstract][Full Text] [Related]
6. O-GlcNAc modification in diabetes and Alzheimer's disease.
Dias WB; Hart GW
Mol Biosyst; 2007 Nov; 3(11):766-72. PubMed ID: 17940659
[TBL] [Abstract][Full Text] [Related]
7. Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation.
Xian YF; Mao QQ; Wu JC; Su ZR; Chen JN; Lai XP; Ip SP; Lin ZX
J Alzheimers Dis; 2014; 39(2):331-46. PubMed ID: 24164737
[TBL] [Abstract][Full Text] [Related]
8. Chronic hyperglycemia induces tau hyperphosphorylation by downregulating OGT-involved O-GlcNAcylation in vivo and in vitro.
Huang R; Tian S; Zhang H; Zhu W; Wang S
Brain Res Bull; 2020 Mar; 156():76-85. PubMed ID: 31931119
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-like peptide-1 protects hippocampal neurons against advanced glycation end product-induced tau hyperphosphorylation.
Chen S; An FM; Yin L; Liu AR; Yin DK; Yao WB; Gao XD
Neuroscience; 2014 Jan; 256():137-46. PubMed ID: 24183963
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of glycogen synthase kinase-3β by Angelica sinensis extract decreases β-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons.
Zhang Z; Zhao R; Qi J; Wen S; Tang Y; Wang D
J Neurosci Res; 2011 Mar; 89(3):437-47. PubMed ID: 21259330
[TBL] [Abstract][Full Text] [Related]
11. Propofol may protect PC12 cells from β-amyloid₂₅₋₃₅ induced apoptosis through the GSK-3β signaling pathway.
Zhang R; Xu J; Liu YY; Zuo PP; Yang N; Ji C; Wang Y; Wang H; Wu AS; Yue Y
Chin Med J (Engl); 2013; 126(10):1884-9. PubMed ID: 23673104
[TBL] [Abstract][Full Text] [Related]
12. Effect of amyloid-Β (25-35) in hyperglycemic and hyperinsulinemic rats, effects on phosphorylation and O-GlcNAcylation of tau protein.
Lozano L; Guevara J; Lefebvre T; Ramos-Martinez I; Limón D; Díaz A; Cerón E; Zenteno E
Neuropeptides; 2017 Jun; 63():18-27. PubMed ID: 28427866
[TBL] [Abstract][Full Text] [Related]
13. Roles of O-GlcNAcylation on amyloid-β precursor protein processing, tau phosphorylation, and hippocampal synapses dysfunction in Alzheimer's disease.
Zheng BW; Yang L; Dai XL; Jiang ZF; Huang HC
Neurol Res; 2016 Feb; 38(2):177-86. PubMed ID: 27078700
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
